Intracerebroventricular administration of ouabain to rats changes the expression of NMDA receptor subunits in cerebral cortex and hippocampus

Neurochemical Research

Volumn 34, Issue 9, 2009, Pages 1650-1657

  Bersier, María Geraldina ^a   Rodríguez De Lores Arnaiz, Georgina ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Cerebral cortex; Hippocampus; Na+, K+ ATPase inhibitor; NMDA receptor subunits; Ouabain

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2C; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2D; OUABAIN; RECEPTOR ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; REGULATORY MECHANISM; WESTERN BLOTTING;

ANIMALS; CEREBRAL CORTEX; GENE EXPRESSION REGULATION; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; MALE; OUABAIN; PROTEIN SUBUNITS; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

RATTUS; RATTUS NORVEGICUS; STROPHANTHUS GRATUS;

EID: 68349144128     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-009-9956-1     Document Type: Article

References (52)

1. Albers RW, Siegel GJ (2006) Membrane transport. In: Siegel GJ, Albers RW, Brady ST et al (eds) Basic neurochemistry. Molecular, cellular, and medical aspects, 7th edn. Elsevier, Massachusetts, pp 73-94
2. +-ATPase in the brain: structure and function. In: Reith MEA and Lajtha A (eds) Neural membranes and transport (volume ed). Handbook of neurochemistry and molecular neurobiology, vol 11. Springer, Berlin, pp 209-224
3. GJ Lees W Leong 1995 The sodium-potasium ATPase inhibitor ouabain is neurotoxic in the rat substantia nigra and striatum Neurosci Lett 188 113 116 10.1016/0304-3940(95)11413-Q
4. MA Cousin DG Nicholls JM Pocock 1995 Modulation of ion gradients and glutamate release in cultured cerebellar granule cells by ouabain J Neurochem 64 2097 2104
5. K Moriyoshi M Masu T Ishii 1991 Molecular cloning and characterization of the rat NMDA receptor Nature 354 31 37 10.1038/354031a0
6. H Meguro H Mori K Araki 1992 Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs Nature 357 70 74 10.1038/357070a0
7. R Dingledine K Borges D Bowie 1999 The glutamate receptor ion channels Pharmacol Rev 51 7 61
8. Hassel B, Dingledine R (2006) Glutamate. In: Siegel GJ, Albers RW, Brady ST et al (eds) Basic neurochemistry. Molecular, cellular, and medical aspects, 7th edn. Elsevier, Massachusetts, pp 267-290
9. J Nacher BS McEwen 2006 The role of N-methyl-d-aspartate receptor in neurogenesis Hippocampus 16 267 270 10.1002/hipo.20160
10. GL Collingridge SJ Kehl H McLennan 1983 Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus J Physiol 334 33 46
11. SW D'Souza SE McConnell P Slater 1993 Glycine site of the excitatory amino acid N-methyl-d-aspartate receptor in neonatal and adult brain Arch Dis Child 69 212 215 10.1136/adc.69.2.212
12. MF Beal 1992 Mechanisms of excitotoxicity in neurologic diseases FASEB J 6 3338 3344
13. N Nakamichi H Oikawa Y Kambe 2004 Relevant modulation by ferrous ions of N-methyl-d-aspartate receptors in ischemic brain injuries Curr Neurovasc Res 1 429 440 10.2174/1567202043361910
14. CW Lindsley WD Shipe SE Wolkenberg 2006 Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia Curr Top Med Chem 6 771 785 10.2174/156802606777057599
15. B Meldrum J Garthwaite 1990 Excitatory amino acid neurotoxicity and neurodegenerative disease Trends Pharmacol Sci 11 379 387 10.1016/0165-6147(90) 90184-A (Pubitemid 20262465)
16. JT Greenamyre 1993 Glutamate-dopamine interactions in the basal ganglia: relationship to Parkinson's disease J Neural Transm Gen 91 255 269 10.1007/BF01245235
17. CW Cotman JW Geddes RJ Bridges 1989 N-methyl-d-aspartate receptors and Alzheimer's disease Neurobiol Aging 10 618 620 10.1016/0197-4580(89)90144-9 (Pubitemid 19245483)
18. J Sánchez-Prieto TS Sihra DG Nicholls 1987 Characterization of the exocytotic release of glutamate from guinea-pig cerebral cortical synaptosomes J Neurochem 49 58 64 10.1111/j.1471-4159.1987.tb03394.x
19. +-ATPase inhibitor Neurochem Res 30 479 486 10.1007/s11064-005-2684-2 (Pubitemid 40933657)
20. ML Brines RJ Robbins 1992 Inhibition of α2/α3 sodium pump isoforms potentiates glutamate neurotoxicity Brain Res 591 94 102 10.1016/0006-8993(92)90982-F
21. + pump isoform activities in neurons Neuroreport 10 3289 3293 10.1097/00001756-199911080-00008
22. HSG Kalluri AK Mehta MK Ticku 1998 Up-regulation of NMDA receptor subunits in rat brain following chronic ethanol treatment Brain Res Mol Brain Res 58 221 224 10.1016/S0169-328X(98)00112-0 (Pubitemid 28352249)
23. UK Laemmli 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 680 685 10.1038/227680a0
24. OH Lowry NJ Rosebrough AL Farr 1951 Protein measurement with the Folin phenol reagent J Biol Chem 193 265 275
25. GJ Lees W Leong 1994 Brain lesions induced by specific and non-specific inhibitors of sodium-potassium ATPase Brain Res 649 225 233 10.1016/0006- 8993(94)91068-5 (Pubitemid 24197216)
26. +-ATPase inhibitor ouabain in causing neuronal lesions in the rat hippocampus Brain Res 714 145 155 10.1016/0006-8993(95)01518-3 (Pubitemid 26120802)
27. BH Westerink G Damsma JB de Vries 1989 Effect of ouabain applied by intrastriatal microdialysis on the in vivo release of dopamine, acetylcholine, and amino acids in the brain of conscious rats J Neurochem 52 705 712 10.1111/j.1471-4159.1989.tb02512.x (Pubitemid 19067525)
28. +-ATPase inhibitor. Comparison with ouabain Neurochem Int 39 301 310 10.1016/S0197-0186(01)00034-1 (Pubitemid 32817100)
29. T Ishii K Moriyoshi H Sugihara 1993 Molecular characterization of the family of the N-methyl-d-aspartate receptor subunits J Biol Chem 268 2836 2843
30. DJ Goebel MS Poosch 1999 NMDA receptor subunit gene expression in the rat brain: a quantitative analysis of endogenous mRNA levels of NR1Com, NR2A, NR2B, NR2C, NR2D and NR3A Brain Res Mol Brain Res 69 164 170 10.1016/S0169-328X(99) 00100-X (Pubitemid 29253809)
31. H Monyer N Burnashev DJ Laurie 1994 Developmental and regional expression in the rat brain and functional properties of four NMDA receptors Neuron 12 529 540 10.1016/0896-6273(94)90210-0 (Pubitemid 24100885)
32. G Krapivinsky L Krapivinsky Y Manasian 2003 The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1 Neuron 40 775 784 10.1016/S0896-6273(03)00645-7 (Pubitemid 37431037)
33. MJ Kim AW Dunah Y Wang 2005 Differential roles of NR2A- and NR2B-containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking Neuron 46 745 760 10.1016/j.neuron.2005.04.031 (Pubitemid 40733130)
34. CG Yu RP Yezierski 2005 Activation of the ERK1/2 signaling cascade by excitotoxic spinal cord injury Brain Res Mol Brain Res 138 244 255 10.1016/j.molbrainres.2005.04.013 (Pubitemid 41138044)
35. PJ Mulholland NT Luong JJ Woodward 2008 Brain-derived neurotrophic factor activation of extracellular signal-regulated kinase is autonomous from the dominant extrasynaptic NMDA receptor extracellular signal-regulated kinase shutoff pathway Neuroscience 151 419 427 10.1016/j.neuroscience.2007.11.001
36. D Lichtstein D Minc Y Shimoni 1985 Demonstration of an ouabainlike plasma compound in hypertension prone and hypertension resistant rats Hypertension 7 729 733
37. +-ATPase Int J Biochem 12 353 359 10.1016/0020-711X(80)90114-7 (Pubitemid 11194762)
38. M Fujino S Fujino 1995 An immunohistochemical study of the significance of a new 31.5-kD ouabain receptor protein isolated from cat cardiac muscle Jpn J Pharmacol 67 125 135 10.1254/jjp.67.125
39. A Goto K Yamada N Yagi 1992 Physiology and pharmacology of endogenous digitalis-like factors Pharmacol Rev 44 3 377 399
40. +-ATPase regulators Mol Neurobiol 6 359 375 10.1007/BF02757941
41. G Rodríguez de Lores Arnaiz 2000 How many endobains are there? Neurochem Res 25 1421 1430 10.1023/A:1007620918408
42. +-ATPase interaction with a brain endogenous inhibitor (endobain E) Neurochem Int 33 425 433 10.1016/S0197-0186(98)00046-1 (Pubitemid 28559221)
43. +-ATPase inhibitor (endobain E) enhances norepinephrine release in rat hypothalamus Neuroscience 90 573 579 10.1016/S0306-4522(98)00421-7 (Pubitemid 29161405)
44. +-ATPase inhibitor, decreases norepinephrine uptake in rat hypothalamus Life Sci 76 359 365 10.1016/j.lfs.2004.09.004 (Pubitemid 39458304)
45. S Pereyra-Alfonso MG López Ordieres MV Armanino 2005 High-affinity neurotensin receptor is involved in phosphoinositide hydrolysis stimulation by carbachol in neonatal rat brain Dev Brain Res 154 247 254 10.1016/j.devbrainres. 2004.11.003 (Pubitemid 40221869)
46. 3H]ifenprodil binding in rat brain membranes J Pharmacol Exp Ther 280 584 592
47. MJ Gallagher H Huang DR Lynch 1998 Modulation of the N-methyl-d-aspartate receptor by haloperidol: NR2B-specific interactions J Neurochem 70 2120 2128
48. H Toyoda R Takahata Y Inayama 1997 Effect of antipsychotic drugs on the gene expression of NMDA receptor subunits in rats Neurochem Res 22 249 252 10.1023/A:1022426402611 (Pubitemid 27091811)
49. AC Chen B McDonald SJ Moss 1998 Gene expression studies of mRNAs encoding the NMDA receptor subunits NMDAR1, NMDAR2A, NMDAR2B, NMDAR2C, and NMDAR2D following long-term treatment with cis-and trans-flupenthixol as a model for understanding the mode of action of schizophrenia drug treatment Brain Res Mol Brain Res 54 92 100 10.1016/S0169-328X(97)00326-4 (Pubitemid 28119164)
50. T Hanaoka H Toyoda T Mizuno 2003 Alterations in NMDA receptor subunit levels in the brain regions of rats chronically administered typical or atypical antipsychotic drugs Neurochem Res 28 919 924 10.1023/A:1023231611616 (Pubitemid 36438410)
51. RG Oretti G Spurlock PR Buckland 1994 Lack of effect of antipsychotic and antidepressant drugs on glutamate receptor mRNA levels in rat brains Neurosci Lett 177 39 43 10.1016/0304-3940(94)90039-6 (Pubitemid 24269424)
52. +-ATPase inhibitor Neurochem Res 33 66 72 10.1007/s11064-007-9412-z (Pubitemid 350242792)